Skip to content

MIVetsCan: Can-Coach Trial (Phase 1)

MIVetsCan: Cannabis Coaching for Veteran Pain Management Trial (Phase 1)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06320470
Enrollment
22
Registered
2024-03-20
Start date
2023-08-07
Completion date
2023-12-11
Last updated
2024-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Keywords

Veteran, Cannabis

Brief summary

The goal of the MIVetsCan Can-Coach Trial is to pilot and modify a trial of four coaching sessions to help Veterans with chronic pain use their own cannabis products more effectively to manage pain and related symptoms.

Detailed description

All study interactions will be done virtually and recruitment data is exploratory.

Interventions

The initial session will last about 45 to 60 minutes. The subsequent 3 sessions are anticipated to take about 20-30 minutes.

Sponsors

Michigan, State of, Licensing and Regulatory Affairs
CollaboratorUNKNOWN
University of Michigan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* United States Veteran * Experiencing chronic pain (pain lasting 3 or more months) * Worst pain of ≥3 out of 10 using a 0-10 Numeric Rating Scale (NRS) * Are planning or currently using cannabidiol (CBD) or cannabis products for pain management * Able to read and speak English sufficiently to allow for informed consent and active participation in the educational intervention sessions * Willingness to attend all study visits (conducted virtually) * Willingness to fill out periodic assessments via smartphone to assess symptom status and cannabis use (protocol has more details)

Exclusion criteria

* Inability to provide informed consent (e.g., cognitive impairment, unable to sufficiently communicate in English) * Participant states participant is pregnant * Current diagnosis or past history of a psychotic disorder (schizophrenia spectrum, except substance/medication -induced or due to another condition) * Current diagnosis or past history of bipolar disorder * Unable to attend study visits * Risk for eminent harm - Suicidal ideation or wish to die as assessed with the Positive and Negative Suicide Ideation (PANSI) questionnaire and further risk assessment by study team members * Any impairment, activity, behavior, or situation that in the judgment of the study team would prevent satisfactory completion of the study protocol

Design outcomes

Primary

MeasureTime frameDescription
Patient Global Impression of Change (PGIC) scoreWeek 14Patient's Global Impression of Change (PGIC) scale will be used. This is a 7 point scale ranging from 1 (very much worse) to 7 (very much better).

Secondary

MeasureTime frameDescription
Average satisfaction level of the cannabis coaching overall assessed from a single survey question on satisfaction.Following intervention, up to approximately Week 14Self-report during the end of treatment survey, from not at all satisfied (1), somewhat satisfied (2), satisfied (3), very satisfied (4), completely satisfied (5).
Average helpfulness level of the cannabis coaching assessed from a single survey question on cannabis coaching.Following intervention, up to approximately Week 14Measured from self-report during the end of treatment survey, from not at all helpful (1), somewhat helpful (2), helpful (3), very helpful (4), completely helpful (5).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026